New York, NY – In proceedings held before both the Federal and State court in Philadelphia, Glaxo (GSK) the manufacturer of Avandia has asserted that it expects a significant number of new claims to be filed by May 21, 2010. This date, it contends, is the filing deadline for claims made by residents of 25 states which follow a three year statute of limitations. DrugSettlement.com and its affiliated attorneys have put in place a program to assist all who come forward by May 1, 2010, to file the necessary paperwork to preserve their rights to compensation. This will probably be the last opportunity for Avandia® users who suffered, heart attacks, heart failure or other cardiovascular problems which may have been caused by the use of Avandia® to seek compensation.
Avandia, used to treat diabetes, has been found to significantly increase the risk of certain cardiovascular disorders. FDA safety reviewers are urging a recall of the drug Avandia® due to increased risk of heart attacks. Congressional investigators have asserted that GlaxoSmithKline knew that Avandia® could cause heart damage several years before a medical study documented the reports. US Senators commented that the company pressured doctors into retracting warnings about the side effects. An Avandia® recall now could possibly extend the time to file a claim.
Financial experts have reported that GSK may have to pay as much as $6 billion dollars to compensate Avandia victims, as part of any Avandia® settlement.
If you or a loved one have been injured by exposure to Avandia® or have suffered any heart complications while using Avandia® you are urged to go to www.DrugSettlement.com immediately to secure your rights to compensation.